WAPO: Companies are not creating drugs the will deal with future pandemics--this could be a big problem in the future. And if some of the labs are in China, aren't we vulnerable to the Chinese government and its scientists' abilities?
Between 1945 and 1968, drug companies invented 13 new categories of
antibiotics, said Allan Coukell, director of medical programs at the Pew Health Group.
Between 1968 and today, just two new categories of antibiotics have
arrived.
In 2011, the Food and Drug Administration approved one new antibiotic, which
fights one of the many bacteria, Clostridium difficile, causing deadly
hospital-borne infections.
“What kept us out of trouble for the last 60 years is that every time drug
resistance caught up to us, the pharmaceutical companies would go back to the
drawing board and develop the next generation of drugs to keep us ahead of the
game,” said Brad Spellberg, an infectious diseases physician in Los
Angeles who heads a microbial resistance task force for the Infectious
Diseases Society of America. “That’s the part of the equation that’s
changed. Drug companies are no longer trying to get one step ahead.”
No comments:
Post a Comment